157 filings
Page 6 of 8
8-K
4j4yzw6 f2
7 Aug 19
Company successfully completed the first of two planned human factors studies
8:13am
8-K
pptgjivxzm0hjr6h
20 Jun 19
Submission of Matters to a Vote of Security Holders
5:04pm
8-K
50fan
4 Jun 19
Entry into a Material Definitive Agreement
4:47pm
8-K
mu6kri bl11j6m
8 May 19
Provides Business Update
8:10am
DEFA14A
qu4ht5gh2gxaj88j
30 Apr 19
Additional proxy soliciting materials
4:22pm
8-K
o4b6n3rj2esc
21 Mar 19
Signed development agreement with West Pharmaceutical Services for next-generation FUROSCIX®On-Body Infusor
8:06am
EFFECT
vcr1idbt13
11 Feb 19
Notice of effectiveness
12:00am
UPLOAD
pb6szec1o1
8 Feb 19
Letter from SEC
12:00am
CORRESP
mubzvcyew6kek5wdycz
7 Feb 19
Correspondence with SEC
12:00am
8-K
33hz2mxsc0r6
29 Jan 19
Entry into a Material Definitive Agreement
8:06am
S-8
q2ys23mi3k45j37qa0g
3 Jan 19
Registration of securities for employees
4:23pm
S-3
0p5fkoa 2d9ve0p
3 Jan 19
Shelf registration
4:16pm
8-K
yzq2j38ztz81 7e8h
3 Jan 19
Index to Financial Statements
4:12pm
8-K
stfkvxg
27 Nov 18
Entry into a Material Definitive Agreement
4:15pm
8-K
v5jb95
13 Nov 18
Results of Operations and Financial Condition
8:10am
8-K
aaz4qpnvccsb11o43wrc
22 Oct 18
Departure of Directors or Certain Officers
8:00am